Home » Topics » Regulatory » Patents

Patents
RSS

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Roche presents new metabotropic glutamate receptor ligands in the patent literature

April 6, 1999

Novel furansulfonic acid compounds for neurodegenerative, autoimmune and inflammatory disorders

April 6, 1999

Patent issued for new Merck glucagon antagonists

April 5, 1999

Therapeutically useful PDE4 inhibitors in development at ADIR

April 5, 1999

Inhibitors of the formation of AGTs described by Alteon

April 5, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...